Moderated by journalist Daniel Fiévet, the round table will give the floor to four leading figures in the field of innovation, who will review the major challenges facing research and innovation today and in the future:
Philippe Aghion is Professor at the Collège de France and holds the Institutions, Innovation and Growth Chair. He also teaches at Harvard and the London School of Economics. Previously, he was a professor at Harvard University, Massachusetts Institute of Technology, CNRS, Oxford University and University College London. He is a Fellow of the Econometric Society and of the American Academy of Arts and Sciences. His work focuses on growth theory and the knowledge economy. With Peter Howitt, he developed the Schumpeterian model of economic growth. Philippe Aghion is the author of Repenser la croissance économique (Fayard, 2016).
Bernard Bigot, recently appointed head of the international ITER research program, has pursued a triple career in science, academia and administration. An alumnus of the prestigious ENS de Saint-Cloud, he was behind the creation of the École normale supérieure de Lyon. Mr. Bigot has held important positions within the French Ministries of Education and Research. Since 2008, he has been High Representative for the ITER program in France (HRFI). He is the author of over seventy scientific publications in the field of theoretical chemistry.
Claire Mathieu researches algorithm design and analysis. She specializes in approximate solutions for Combinatorics optimization problems. She is a CNRS research director in computer science. She held the Computer Sciences and Digital Sciences Chair at the Collège de France in 2017-2018, helped design the Parcoursup algorithms and was awarded the 2019 CNRS Silver Medal.
A neuroscientist by training, co-founder and CEO of iBionext, Alexia Perouse is an expert in the financing of healthcare innovation. In 2015, she co-founded the iBionext management company with Bernard Gilly, whose methodology puts human expertise at the heart of the action. Previously, Alexia was Associate Director in charge of healthcare funds at Omnes Capital (Ex-Crédit Agricole Private Equity). She has held a dozen board positions in public and private companies, and has been involved in eight exits via industrial sale or initial public offering (IPO). Alexia joined the venture capital industry in 1999.
